Company attributes
Location
CEO
Founder
Pitchbook URL
Email Address
media@newtonbiocapital.com0
Full Address
Global Life Science Hub Nihonbashi Muromachi Mitsui Tower 7F 3-2-1 Nihonbashi Muromachi, Chuo-Ku Tokyo 103-0022 Japan0
Avenue de Tervueren 273 Tervurenlaan 1150 Brussels Belgium0
Founded Date
2015
CFO
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Newton Biocapital is a venture capital firm in Belgium that focuses on financing biotech and life science projects. Founded 2017 in Brussels Hoofdstedelijk Gewest, Belgium by Alain Parthoens, it invests in early stage ventures and seed. Its portfolio companies include Acticor Biotech, EditForce, Sequana Medical, ChromaCure, Synergia Medical and DIM3. As of March 2020, Newton Biocapital has made seven investments. Their most recent investment was on November 6, 2019, when Acticor Biotech raised €7M. Newton Biocapital has had one exit, which was Sequana Medical. The company has raised a single venture fund, Newton Biocapital i S.A. Pricaf. This fund was announced on January 1, 2017 and raised a total of €82M.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
